144 related articles for article (PubMed ID: 23941591)
1. Impaired slow axonal transport in diabetic peripheral nerve is independent of RAGE.
Juranek JK; Geddis MS; Rosario R; Schmidt AM
Eur J Neurosci; 2013 Oct; 38(8):3159-68. PubMed ID: 23941591
[TBL] [Abstract][Full Text] [Related]
2. RAGE deficiency improves postinjury sciatic nerve regeneration in type 1 diabetic mice.
Juranek JK; Geddis MS; Song F; Zhang J; Garcia J; Rosario R; Yan SF; Brannagan TH; Schmidt AM
Diabetes; 2013 Mar; 62(3):931-43. PubMed ID: 23172920
[TBL] [Abstract][Full Text] [Related]
3. RAGE modulates peripheral nerve regeneration via recruitment of both inflammatory and axonal outgrowth pathways.
Rong LL; Yan SF; Wendt T; Hans D; Pachydaki S; Bucciarelli LG; Adebayo A; Qu W; Lu Y; Kostov K; Lalla E; Yan SD; Gooch C; Szabolcs M; Trojaborg W; Hays AP; Schmidt AM
FASEB J; 2004 Dec; 18(15):1818-25. PubMed ID: 15576485
[TBL] [Abstract][Full Text] [Related]
4. Antagonism of RAGE suppresses peripheral nerve regeneration.
Rong LL; Trojaborg W; Qu W; Kostov K; Yan SD; Gooch C; Szabolcs M; Hays AP; Schmidt AM
FASEB J; 2004 Dec; 18(15):1812-7. PubMed ID: 15576484
[TBL] [Abstract][Full Text] [Related]
5. Receptor for advanced glycation end products (RAGEs) and experimental diabetic neuropathy.
Toth C; Rong LL; Yang C; Martinez J; Song F; Ramji N; Brussee V; Liu W; Durand J; Nguyen MD; Schmidt AM; Zochodne DW
Diabetes; 2008 Apr; 57(4):1002-17. PubMed ID: 18039814
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of the ligand-RAGE pathway via the angiotensin II type I receptor is essential in the pathogenesis of diabetic atherosclerosis.
Ihara Y; Egashira K; Nakano K; Ohtani K; Kubo M; Koga J; Iwai M; Horiuchi M; Gang Z; Yamagishi S; Sunagawa K
J Mol Cell Cardiol; 2007 Oct; 43(4):455-64. PubMed ID: 17761193
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational modifications of nerve cytoskeletal proteins in experimental diabetes.
McLean WG; Pekiner C; Cullum NA; Casson IF
Mol Neurobiol; 1992; 6(2-3):225-37. PubMed ID: 1476675
[TBL] [Abstract][Full Text] [Related]
8. RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
Wendt T; Harja E; Bucciarelli L; Qu W; Lu Y; Rong LL; Jenkins DG; Stein G; Schmidt AM; Yan SF
Atherosclerosis; 2006 Mar; 185(1):70-7. PubMed ID: 16076470
[TBL] [Abstract][Full Text] [Related]
9. Wallerian degeneration and axonal regeneration after sciatic nerve crush are altered in ICAM-1-deficient mice.
Kirsch M; Campos Friz M; Vougioukas VI; Hofmann HD
Cell Tissue Res; 2009 Oct; 338(1):19-28. PubMed ID: 19657676
[TBL] [Abstract][Full Text] [Related]
10. Impaired induction of vasoactive intestinal polypeptide after sciatic nerve injury in the streptozotocin-diabetic rat.
Calcutt NA; Mizisin AP; Yaksh TL
J Neurol Sci; 1993 Nov; 119(2):154-61. PubMed ID: 8277329
[TBL] [Abstract][Full Text] [Related]
11. Axonal transport in early experimental diabetes.
Sidenius P; Jakobsen J
Brain Res; 1979 Sep; 173(2):315-30. PubMed ID: 90540
[TBL] [Abstract][Full Text] [Related]
12. Diabetes, leukoencephalopathy and rage.
Toth C; Schmidt AM; Tuor UI; Francis G; Foniok T; Brussee V; Kaur J; Yan SF; Martinez JA; Barber PA; Buchan A; Zochodne DW
Neurobiol Dis; 2006 Aug; 23(2):445-61. PubMed ID: 16815028
[TBL] [Abstract][Full Text] [Related]
13. Enhanced activation of axonally transported stress-activated protein kinases in peripheral nerve in diabetic neuropathy is prevented by neurotrophin-3.
Middlemas A; Delcroix JD; Sayers NM; Tomlinson DR; Fernyhough P
Brain; 2003 Jul; 126(Pt 7):1671-82. PubMed ID: 12805110
[TBL] [Abstract][Full Text] [Related]
14. Altered axonal transport of cytoskeletal proteins in the mutant diabetic mouse.
Vitadello M; Filliatreau G; Dupont JL; Hassig R; Gorio A; Di Giamberardino L
J Neurochem; 1985 Sep; 45(3):860-8. PubMed ID: 2411858
[TBL] [Abstract][Full Text] [Related]
15. RAGE-TXNIP axis is required for S100B-promoted Schwann cell migration, fibronectin expression and cytokine secretion.
Sbai O; Devi TS; Melone MA; Feron F; Khrestchatisky M; Singh LP; Perrone L
J Cell Sci; 2010 Dec; 123(Pt 24):4332-9. PubMed ID: 21098642
[TBL] [Abstract][Full Text] [Related]
16. Acute treatment with pulsed electromagnetic fields and its effect on fast axonal transport in normal and regenerating nerve.
Sisken BF; Jacob JM; Walker JL
J Neurosci Res; 1995 Dec; 42(5):692-9. PubMed ID: 8600302
[TBL] [Abstract][Full Text] [Related]
17. Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Shoji T; Koyama H; Morioka T; Tanaka S; Kizu A; Motoyama K; Mori K; Fukumoto S; Shioi A; Shimogaito N; Takeuchi M; Yamamoto Y; Yonekura H; Yamamoto H; Nishizawa Y
Diabetes; 2006 Aug; 55(8):2245-55. PubMed ID: 16873687
[TBL] [Abstract][Full Text] [Related]
18. Parvalbumin is reduced in the peripheral nerves of diabetic rats.
Endo T; Onaya T
J Clin Invest; 1986 Nov; 78(5):1161-4. PubMed ID: 3771787
[TBL] [Abstract][Full Text] [Related]
19. Neurotrophin-3 reverses nerve conduction velocity deficits in streptozotocin-diabetic rats.
Mizisin AP; Calcutt NA; Tomlinson DR; Gallagher A; Fernyhough P
J Peripher Nerv Syst; 1999; 4(3-4):211-21. PubMed ID: 10642089
[TBL] [Abstract][Full Text] [Related]
20. Alterations in slow transport kinetics induced by estramustine phosphate, an agent binding to microtubule-associated proteins.
Sahenk Z; Mendell JR
J Neurosci Res; 1992 Aug; 32(4):481-93. PubMed ID: 1382136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
